Cancer Genetics and Psychotherapy 1st ed. 2017 Edition
[amazon template=iframe image2&asin=331964548X]
Cancer is the scandal magic event of Nature. Psycho-Oncogenetic is an insight for research, education, and translated cancer medicine that open a new window to patients, psychologists, surgeons, oncologists, haematologists, geneticists and scientists who are aimed to pave the ways towards an alternative management for cancer patients. Being cooperative, innovative, perceptive, and inspired are some essential characteristics for, participating in cancer translated research. Applicability of suggestive complementary insights including Pharmacogenomics (PG), Pharmacokinetics (PK), Pharmaco-Psycho-Somatic (PPS), Pharmaco-Psycho-Genomics (PPG), Pharmaco-Psycho-Kinetics (PPK), may facilitate the access of the Personalized Pharmaco-Therapy (PPT) as the reliable target-based strategy. So, by bridging Pharmacogenetics to Psycho-Genetics, the harmonized and multi- target-based insights would, gradually, facilitate to connect the initial station of cancer coach to the final station of cancer management, which is the appropriate individualized cancer therapy. In this regards, the global insight is required to be replaced by the personalized cascade management from A to Z.
It was my task and aim to consider a comprehensive manner in editing of this book. This endeavor was relied on the authors and co-authors who have, greatly, contributed to this package which will, hopefully, spread the provided basic and applicable scientific, and clinical messages to the audiences who play roles in the cancer world. The contents of this book include 26 chapters including basic Science/Genetics, psychology and clinical aspects in different tumors. The contents of this package may inspire a profounder concern of coordinated strategy in cancer research and cancer management. Besides, it may also provide some clues to positioning of puzzles for innovating the target-based cancer therapy. Let’s move towards planning an appropriate social life style with an individualized diagnosis and management for cancer patients. By considering the global sharing, triggering the burdens is the key aim in cancer.
About the Author
Professor Parvin Mehdipour has mainly focused on Cancer Genetics by considering the multi-disciplinary manner in her academic and research life through 34 years in Tehran University of Medical Sciences. She was inspired by puzzling the road maps of Genetic and tumor biology to find the directions and cross roads in cancer and cross-talk between the cancer cells. She had scientific links with DKFZ, Institutes of Human Genetics and Institute of Medical Genetics in Erlangen-Nuerenberg, Bonn, Humboldt/berlin, Dresden- and Manchester- University. She has initiated a cancer project on leukemia at Department of Genetics, Royal Liverpool hospital, University of Liverpool as her PhD thesis. Since then she was exploring on solid tumors to prove the cancer evolution and hypotheses in different cancers including breast and brain tumors and also tracing cancer biomarkers. Her aims and focal interests during last 20 years included early detection through Circulating Tumor Cells (CTCs) in cancer journey and innovating modeling of the metastatic cancer. The final destination of her task is personalized cancer managements and drug innovation. Her interests include painting, writing and nutrigenomics.